AstraZeneca vaccine investigation underway over reports of Guillain-Barre syndrome cases
THE European Union’s medicines regulator is reviewing reports of a rare condition affecting the nerves following vaccination with the Oxford/AstraZeneca coronavirus jab.
Daily Express :: World Feed
Comments are closed.